CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue
Housing	$ 80,650	$ 0
Commercial rental	0	0
Tissue array products	68,136	151,152
Total revenue	148,786	151,152
Cost of Sales
Housing	47,145	0
Commercial rental - related party	26,299	16,696
Tissue array products	68,070	98,520
Total cost of sales	141,514	115,216
Gross Profit	7,272	35,936
Operating Expenses:
Salaries and wages	50,988	53,913
Depreciation and amortization	11,422	33,445
Bad debt expense	0	6,630
Professional fees	38,575	40,107
Selling and distribution expenses	2,861	4,186
Other general and administrative expenses	123,538	27,592
Total Operating Expenses	227,384	165,873
Loss from Operations	(220,112)	(129,937)
Other Expense
Interest expenses, net	(47,472)	(46,188)
Other expense, net	(767)	(2,048)
Total Other Expense, Net	(48,239)	(48,236)
Loss before Income Taxes	(268,351)	(178,173)
Less: Income Tax (Benefit) Expense	(1,738)	142
Net loss	(266,613)	(178,315)
Less: Net loss attributable to the non-controlling interests	(33,480)	(31,493)
Net loss attributable to CYBRDI, INC.	(233,133)	(146,822)
Foreign currency translation loss	(70,556)	(37,094)
Comprehensive loss	$ (303,689)	$ (183,916)
Net Loss Per Common Share
Basic and Diluted	$ 0.00	$ 0.00
Weighted Average Number of Shares Outstanding
Basic and Diluted	120,225,323	120,225,323